JiscMail Logo
Email discussion lists for the UK Education and Research communities

Help for ACB-CLIN-CHEM-GEN Archives


ACB-CLIN-CHEM-GEN Archives

ACB-CLIN-CHEM-GEN Archives


ACB-CLIN-CHEM-GEN@JISCMAIL.AC.UK


View:

Message:

[

First

|

Previous

|

Next

|

Last

]

By Topic:

[

First

|

Previous

|

Next

|

Last

]

By Author:

[

First

|

Previous

|

Next

|

Last

]

Font:

Proportional Font

LISTSERV Archives

LISTSERV Archives

ACB-CLIN-CHEM-GEN Home

ACB-CLIN-CHEM-GEN Home

ACB-CLIN-CHEM-GEN  February 2012

ACB-CLIN-CHEM-GEN February 2012

Options

Subscribe or Unsubscribe

Subscribe or Unsubscribe

Log In

Log In

Get Password

Get Password

Subject:

Re: TFT panels - correction

From:

"Richard Jones [Pathology]" <[log in to unmask]>

Reply-To:

Richard Jones [Pathology]

Date:

Mon, 20 Feb 2012 09:31:36 +0000

Content-Type:

text/plain

Parts/Attachments:

Parts/Attachments

text/plain (172 lines)

The email address for access to the data is:

[log in to unmask]

not .nhs.uk

www.ychi.leeds.ac.uk/pmipunits is correct for PBCL feedback.

Apols

Rick


________________________________________
From: Clinical biochemistry discussion list [[log in to unmask]] On Behalf Of Richard Jones [Pathology] [[log in to unmask]]
Sent: 13 February 2012 16:55
To: [log in to unmask]; Richard Jones [Pathology]
Subject: Re: TFT panels

Though you might like to see what the balance of policy is across the UK from the use of data mining techniques.

The attached jpeg shows displays of test rates per 1000 patients for data aggregated at PCT level. Each bar is a PCT. The data was extracted anonymously from PMIP as part of the safety audit (still ongoing - see www.ychi.leeds.ac.uk/pmipunits<http://www.ychi.leeds.ac.uk/pmipunits>) and is a short snapshop based on >1m test reports. We can assume PCTs are about equivalent coverage to labs though of course there will be overlap - one wonders how the poor clinicians and patients cope with the variance at the boundaries.

The upper panel shows TSH usage and the lower panel fT4 usage. The visualisation suggests about half the country is using parallel TSH/fT4 and half sequential protocols. By mapping these data to rates of 'missed' / 'late diagnosed' hypopits from HES we could probably answer the clinical effectiveness question once and for all. Hardly anyone is still sending TT4. The variance in terms of tests per patient gets worse as you drill down through PCTs to GP practices just as Stuart Smellie has shown. Whether the patient outcomes are affected is a moot point and cries out for some R&D.

Some of this data is now in the printed version of the Atlas of Variation - see http://www.sepho.org.uk/extras/maps/NHSatlas2011/atlas.html

The dataset includes thyroid ref ranges etc too - Julian Barth has been commissioned by Muir Gray to look into this in depth.

If anyone wants access to the data contact [log in to unmask]<mailto:[log in to unmask]> and they can provide all the IG forms you'll need to fill in.

Rick




________________________________
From: Clinical biochemistry discussion list [[log in to unmask]] On Behalf Of Jonathan Kay [[log in to unmask]]
Sent: 13 February 2012 14:08
To: [log in to unmask]; Richard Jones [Pathology]
Subject: Re: TFT panels

QIPP document on the Core Automated Laboratory in Oxford<http://wwwgoogle.co.uk/url?sa=t&rct=j&q=qipp%20oxford%20laboratory&source=web&cd=2&ved=0CCoQFjAB&url=http://arms.evidencenhs.uk/resources/qipp/29512/attachment&ei=rRc5T8i3KcKBhQf9o6iyCg&usg=AFQjCNEBO9hKwRUEZN2MJ7ss_t8Lqi6wYg&cad=rja>, including some data on TaTs and references.

Jonathan




On 13 Feb 2012, at 13:28, Jonathan Kay wrote:

I'd be interested in how others organise this, but I'm more concerned about staff cost than delay in reporting.

For us:

The cascade overwhelmingly schedules the next assay without human intervention while the specimen is still on the track so there is no staff cost. (Siemens analysers and track.)

We are analysing specimens from primary care 24 x 7 without cut-offs so the delay is typically "one more assay" and would very rarely be perceptible by the GP.

Jonathan


On 13 Feb 2012, at 13:21, Mainwaring-Burton Richard (SOUTH LONDON HEALTHCARE NHS TRUST) wrote:


Does anybody also have data regarding the processing delay introduced ?

This will depend on the number of samples needing reflex testing, with consequential doubled analysis time, as well as all reflexable samples having to be held in results pending space prior to first results availability.

with best wishes
Richard
Richard Mainwaring-Burton
Consultant Biochemist
South London Healthcare Trust
Queen Mary's Hospital, Sidcup
Queen Elizabeth Hospital, Woolwich
Princess Royal Hospital, Farnborough
020-8836-5724
020-8308-3084
mob: 07831-739876

________________________________
From: Clinical biochemistry discussion list [[log in to unmask]] On Behalf Of Jonathan Kay [[log in to unmask]]
Sent: 13 February 2012 11:57
To: [log in to unmask]<mailto:[log in to unmask]>
Subject: Re: TFT panels

PS: There's no theoretical reason why population reference intervals should be the best decision limits for cascading further assays.

Jonathan

On 13 Feb 2012, at 11:56, Jonathan Kay wrote:

Good morning.

There's lots on this in the literature. I suggest you start with Barth's surveys published in Annals. There may also be something on current diversity of practice in recent Keele benchmarking reports.

In Oxford we start with TSH only (except in certain defined groups) and use on-analyser cascade rules from there.

Do you have computerised requesting by clinicians in either or both of primary care and secondary care that you can use as a platform for the rules?

Does anyone have experience of using this platform to implement different pathways for diagnosis and monitoring?

For primary care I am unconvinced by the argument about picking up hypopituitarism making it necessary to start with two assays in all patients. Does anyone have relevant figures on incidence of disease detected in this way or cost-effectiveness?

Jonathan


On 13 Feb 2012, at 11:43, Wainwright Laura - Clinical Scientist wrote:

Morning all,

I would be grateful for a bit of advice from the collective.  Like everywhere, we are under increasing budget pressures and one idea that has come up is to offer only TSH as our first line thyroid panel.  I find this a bit concerning as, even if you reflex FT4 when TSH is outside the reference range, we will no longer pick up hypopit patients.  I would be interested to hear your thoughts on this, particularly from anyone who already has this or a similar strategy in operation
Happy to summarise responses and feed back.
Many thanks,
Laura



Dr Laura Wainwright
Clinical Scientist
Queen Alexandra Hospital
Portsmouth
023 9228 6345
------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk<http://www.acb.org.uk/> Green Laboratories Workhttp://www.laboratorymedicine.nhs.uk<http://www.laboratorymedicine.nhs.uk/> List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/


------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk<http://www.acb.org.uk/> Green Laboratories Workhttp://www.laboratorymedicine.nhs.uk<http://www.laboratorymedicine.nhs.uk/> List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/

********************************************************************************************************************

This message may contain confidential information. If you are not the intended recipient please inform the
sender that you have received the message in error before deleting it
Please do not disclose, copy or distribute information in this e-mail or take any action in reliance on its contents:
to do so is strictly prohibited and may be unlawful.

Thank you for your co-operation.

NHSmail is the secure email and directory service available for all NHS staff in England and Scotland
NHSmail is approved for exchanging patient data and other sensitive information with NHSmail and GSi recipients
NHSmail provides an email address for your career in the NHS and can be accessed anywhere
For more information and to find out how you can switch, visit www.connectingforhealth.nhs.uk/nhsmail<http://www.connectingforhealth.nhs.uk/nhsmail>

********************************************************************************************************************
------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk<http://www.acb.org.uk/> Green Laboratories Work http://www.laboratorymedicine.nhs.uk<http://www.laboratorymedicine.nhs.uk/>List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/


------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk Green Laboratories Work http://www.laboratorymedicine.nhs.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/

------ACB discussion List Information--------
This is an open discussion list for the academic and clinical community working in clinical biochemistry.
Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
Green Laboratories Work
http://www.laboratorymedicine.nhs.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical community working in clinical biochemistry.
Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
Green Laboratories Work
http://www.laboratorymedicine.nhs.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/

Top of Message | Previous Page | Permalink

JiscMail Tools


RSS Feeds and Sharing


Advanced Options


Archives

April 2024
March 2024
February 2024
January 2024
December 2023
November 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
April 2023
March 2023
February 2023
January 2023
December 2022
November 2022
October 2022
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
2006
2005
2004
2003
2002
2001
2000
1999
1998


JiscMail is a Jisc service.

View our service policies at https://www.jiscmail.ac.uk/policyandsecurity/ and Jisc's privacy policy at https://www.jisc.ac.uk/website/privacy-notice

For help and support help@jisc.ac.uk

Secured by F-Secure Anti-Virus CataList Email List Search Powered by the LISTSERV Email List Manager